NDC codes

406279 NDC codes with hospital pricing data in the network.

• NDC 21922-0003-01 — Fluocinolone acetonide 0.01% topical solutionAI (131 hospitals, 177–222 samples)
• NDC 51672-1259-03 — CLOBETASOL 0.05 % TOPICAL OINTMENTAI (75 hospitals, 177–222 samples)
• NDC 00115-1725-01 — Griseofulvin 250 mg tabletAI (33 hospitals, 222 samples)
• NDC 00143-9802-50 — Doxycycline hyclate 50 mg oral capsulesAI (145 hospitals, 177–222 samples)
• NDC 00378-7292-53 — Norethindrone 0.35 mg tablets, 28-packAI (62 hospitals, 177–222 samples)
• NDC 00713-0709-15 — fluocinolone 0.025 % topical creamAI (120 hospitals, 177–222 samples)
• NDC 51672-1395-00 — tretinoin 0.1 % topical creamAI (94 hospitals, 222 samples)
• NDC 59762-0067-01 — Sertraline 20 mg/mL oral concentrate, 60 mL bottleAI (277 hospitals, 177–222 samples)
• NDC 60687-0775-11 — MECLIZINE 12.5 MG TABLETAI (218 hospitals, 222 samples)
• NDC 63323-0815-22 — Amikacin injection solutionAI (79 hospitals, 222 samples)
• NDC 70377-0102-11 — Aminocaproic acid 500 mg oral tabletsAI (159 hospitals, 222 samples)
• NDC 00536-1316-25 — Zinc oxide ointment 20% tubeAI (140 hospitals, 177–222 samples)
• NDC 60505-0145-00 — Omeprazole delayed-release 10 mg capsulesAI (60 hospitals, 177–222 samples)
• NDC 00406-1445-01 — Methylphenidate 10 mg tabletAI (126 hospitals, 177–222 samples)
• NDC 00527-4579-37 — Methylphenidate extended-release capsules 10 mgAI (71 hospitals, 177–222 samples)
• NDC 62484-0015-04 — Hydroxyurea oral solution, 100 mg/mL, 148 mL bottleAI (105 hospitals, 222 samples)
• NDC 52276-0312-60 — Carglumic acid 200 mg tabletsAI (72 hospitals, 222 samples)
• NDC 69097-0868-07 — Nadolol 40 mg tabletAI (113 hospitals, 177–222 samples)
• NDC 70255-0010-02 — Binimetinib 15 mg tablets, bottle of 180AI (104 hospitals, 222 samples)
• NDC 00006-5085-99 — Letermovir 120 mg oral pelletsAI (19 hospitals, 222 samples)
• NDC 00228-2849-03 — Fluvoxamine extended-release 150 mg capsuleAI (46 hospitals, 177–222 samples)
• NDC 60505-3277-03 — Olanzapine 15 mg orally disintegrating tabletAI (72 hospitals, 177–222 samples)
• NDC 85152-2000-08 — DEXTROSE 100 GM ORAL SOLUTION (4 hospitals, 222 samples)
• NDC 00781-3312-95 — Palonosetron (Aloxi) 0.25 mg/5 mL injectionAI (20 hospitals, 141–222 samples)
• NDC 00069-0231-01 — Lorlatinib 100 mg tabletsAI (32 hospitals, 222 samples)
• NDC 00069-0227-01 — Lorlatinib 25 mg tabletAI (54 hospitals, 222 samples)
• NDC 21922-0016-06 — Clobetasol 0.05% cream, 30 gram tubeAI (55 hospitals, 177–222 samples)
• NDC 66993-0897-49 — Betamethasone augmented topical ointment 0.05%AI (29 hospitals, 177–222 samples)
• NDC 00173-0755-00 — Lamotrigine extended-release 50 mg tabletAI (57 hospitals, 177–222 samples)
• NDC 00378-8082-20 — TRETINOIN 0.025 % CREAM 20 G TUBEAI (29 hospitals, 222 samples)
• NDC 00006-5086-01 — Letermovir oral pellets 20 mgAI (26 hospitals, 222 samples)
• NDC 00126-0288-02 — SODIUM FLUORIDE 1.1 % DENTAL GELAI (14 hospitals, 222 samples)
• NDC 09991-1435-00 — AMPICILLIN-SULBACTAM IV SYRINGE 30 MG/ML AMPICILLIN (NEO/PED) FROM STOCK SOLN (1 hospital, 87–222 samples)
• NDC 09991-1436-00 — AMPICILLIN-SULBACTAM IV SYRINGE 30 MG/ML AMPICILLIN (NEO/PED) FROM STOCK SOLN (1 hospital, 87–222 samples)
• NDC 944049302 — Human albumin 25% injection, 100 mLAI (137 hospitals, 77–221 samples)
• NDC 00000-0001-36 — Preservative-free morphine injection for newbornsAI (13 hospitals, 104–221 samples)
• NDC 00005-2500-02 — Calcium polycarbophil 625 mg tabletAI (30 hospitals, 158–221 samples)
• NDC 00054-3117-63 — Calcium carbonate oral liquidAI (177 hospitals, 158–221 samples)
• NDC 00056-0168-01 — Warfarin 4 mg tabletAI (68 hospitals, 158–221 samples)
• NDC 00069-2590-01 — Vancomycin 5 gram intravenous solutionAI (17 hospitals, 41–221 samples)
• NDC 00074-1316-14 — Heparin injection 5,000 units per 0.5 mLAI (15 hospitals, 59–221 samples)
• NDC 00597-0135-60 — Dabigatran 150 mg capsulesAI (94 hospitals, 158–221 samples)
• NDC 00990-7983-25 — sodium chloride 0.9 % intravenous solutionAI (60 hospitals, 167–221 samples)
• NDC 65219-0016-10 — Ampicillin 500 mg injectionAI (160 hospitals, 32–221 samples)
• NDC 63323-0569-99 — Enoxaparin injection 120 mg/0.8 mLAI (124 hospitals, 158–221 samples)
• NDC 517970201 — Droperidol 2.5 mg/mL injectionAI (77 hospitals, 95–221 samples)
• NDC 16729-0043-01 — Tacrolimus 5 mg capsulesAI (337 hospitals, 121–220 samples)
• NDC 55150-0230-00 — Fondaparinux sodium 2.5 mg injectionAI (285 hospitals, 121–220 samples)
• NDC 67457-0584-00 — Fondaparinux sodium 7.5 mg/0.6 mL injectionAI (326 hospitals, 121–220 samples)
• NDC 68462-0685-01 — Tacrolimus 0.5 mg immediate-release capsuleAI (102 hospitals, 121–220 samples)